Bicara Therapeutics' second funding round of $108 million was displayed on New York's Times Square ... [ ] billboard in March 2023.

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% from its IPO price in its first week of trading on Nasdaq as investors on Wall Street gave the cancer drug developer a strong vote of confidence.

The stock jumped 30% on its first trading on September 13 and continued to rally last week to close at $25.61 on Friday, giving Bicara a market capitalization of $1.3 billion. The Boston-based company raised $362 million from its IPO, the size of which........

© Forbes